J.G. Morgan - Concepedia

Author

J.G. Morgan

Culham Science Centre

Also Known As

J G Morgan, J Morgan, J. G. Morgan, J. Guy Morgan, J. Morgan, J.G. Morgan, Morgan, J. Guy, Nick Wong

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Culham Science Centre Tokamak Energy (United Kingdom)University of Oxford University of Manchester Culham Centre for Fusion Energy

About

J.G. Morgan is an author at Culham Science Centre specializing in engineering, physics, and magnetic confinement fusion.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	11	11	762
2	Natural Sciences	4	4	111
3	Applied Physics	3	3	251
4	Medicine	2	2	243
5	Public Health	1	1	94

J.G. Morgan

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
FISPACT-II: An Advanced Simulation System for Activation, Transmutation and Material Modelling Jean-Christophe Sublet, J.W. Eastwood, J.G. Morgan, Nuclear Data Sheets Materials ScienceAdvanced Simulation SystemEngineeringProcess Simulation ModelMaterial Simulation	2017	206
FUTURE, OPPORTUNITIES AND CHALLENGES OF INKJET TECHNOLOGIES J. R. Castrejón-Pita, W. R. S. Baxter, J.G. Morgan, Atomization and Sprays Materials ScienceEngineeringInkjet TechnologyGraphical PrintingMicrofabrication	2013	179
Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: Data for genetic counselling J. C. Bear, P J McManamon, J.G. Morgan, American Journal of Medical Genetics	1984	170
Compact fusion energy based on the spherical tokamak A. Sykes, A.E. Costley, C. G. Windsor, Nuclear Fusion MagnetismEngineeringPhysicsAerospace EngineeringControlled Nuclear Fusion	2017	163
Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia Paul N. Durrington, Mike Mackness, Deepak Bhatnagar, Atherosclerosis Type Iib HyperlipoproteinaemiaThrombosisBiochemistryCardiovascular DiseaseMedicine	1998	149
Indications for cholesterol-lowering medication: comparison of risk-assessment methods PN Durrington, H. Prais, Deepak Bhatnagar, The Lancet Cardiovascular DiseaseCholesterol-lowering MedicationOutcomes ResearchHyperlipidemiaPharmacotherapy	1999	94
Design of cemented tungsten carbide and boride-containing shields for a fusion power plant C. G. Windsor, Jessica Marshall, J.G. Morgan, Nuclear Fusion	2018	72
Physical mapping of the CXC chemokine locus on human chromosome 4 N. O’Donovan, Mary Galvin, J.G. Morgan Cytogenetic and Genome Research	1999	55
Modelling the power deposition into a spherical tokamak fusion power plant C. G. Windsor, J.G. Morgan, P.F. Buxton, Nuclear Fusion Power DepositionElectrical EngineeringEngineeringAerospace EngineeringSuperconductivity	2016	37
Modelling of the boundary plasma of large tokamaks Bastiaan J. Braams, P.J. Harbour, Mark Harrison, Journal of Nuclear Materials EngineeringPhysicsBoundary PlasmaBasic Plasma PhysicMagnetohydrodynamics	1984	36

Page 1